Proteomic analysis in lung tissue of smokers and COPD patients

Keyphrases

• Proteomic Analysis 100%
• Lung Tissue 100%
• Thioredoxin 100%
• Matrix Metalloproteinase 13 (MMP13) 100%
• COPD Patients 100%
• Smoking Patient 100%
• Smokers 75%
• Immunohistochemistry 50%
• Matrix-assisted Laser Desorption Ionization-time of Flight Mass Spectrometry (MALDI-TOF MS) 50%
• Alveolar Macrophages 50%
• Non-smokers 50%
• Bronchial Epithelium 50%
• Healthy Smokers 50%
• Type II Pneumocytes 50%
• Alveolar Type II 50%
• Western Blot 25%
• Cigarette Smoking 25%
• Risk Factors 25%
• Western Blotting 25%
• Proteomics 25%
• Lung 25%
• Protein Spots 25%
• Mass Spectrometry Analysis 25%
• Pathophysiologic Mechanisms 25%
• Tissue Specimens 25%
• Two-dimensional Polyacrylamide Gel Electrophoresis 25%
• Surgery for Lung Cancer 25%

Biochemistry, Genetics and Molecular Biology

• Proteomics 100%
• Smoking 100%
• Matrix Metalloproteinase 66%
• Thioredoxin 66%
• Matrix-Assisted Laser Desorption/Ionization 33%
• Time-of-Flight Mass Spectrometry 33%
• Alveolar Macrophage 33%
• Type II Pneumocyte 33%
• Western Blotting 33%
• Genetics 16%
• Mass Spectrometry 16%
• Cigarette Smoking 16%
• Two Dimensional Polyacrylamide Gel Electrophoresis 16%

Immunology and Microbiology

• Western Blot 100%
• Time-of-Flight Mass Spectrometry 100%
• Matrix-Assisted Laser Desorption-Ionization 100%
• Alveolar Macrophage 100%
• Mass Spectrometry 50%